Aquatic vaccine research

Clinical research will focus around the development and documentation of aquatic vaccines

Malta’s AquaBioTech Group has signed a three year contract with an option for a three year extension for clinical research on aquatic vaccines with Norway’s PHARMAQ AS.

This is premium content

Already a member? SIGN IN now

wf_web_image

Sign up for FREE to continue reading!

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:

  • Weekly newsletters providing valuable news and information on the commercial fishing and aquaculture sector
  • Full access to our news archive
  • Live and archived webinars, podcasts and videos
  • Articles on innovations and current trends in the commercial fishing industry
  • Our extensive archive of data, research and intelligence

Get more free content sign up today

Ready to subscribe? Choose from one of our subscription packages for unlimited access!